Screening for MCAD deficiency in newborns

BMJ (Online)

Volumn 338, Issue 7699, 2009, Pages 843-

  Loughrey, Clodagh ^a   Bennett, Michael J ^b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE;

ASIAN; DIET SUPPLEMENTATION; EDITORIAL; EUROPEAN UNION; FATTY ACID OXIDATION; HEALTH PROGRAM; HETEROZYGOTE; HOMOZYGOSITY; LABORATORY TEST; MEDICAL RESEARCH; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; METABOLIC DISORDER; MUTATION; NEWBORN SCREENING; PRIORITY JOURNAL; PUBLIC HEALTH; RACE DIFFERENCE; TANDEM MASS SPECTROMETRY;

ACYL-COA DEHYDROGENASE; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING;

EID: 67649239031     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b971     Document Type: Editorial

References (13)

1. Blakemore AIF, Singleton H, Pollitt RJ, Engel PC, Kolvraa S, Gregersen N, et al. Frequency of the G985 MCAD mutation in the general population. Lancet 1991;337:298-299[ISI][Medline]
2. Khalid JM, Oerton J, Cortina-Borja M, Andresen BS, Besley G, Dalton RN, et al. UK Collaborative Study of Newborn Screening for MCADD. Ethnicity of children with homozygous c.985A>G medium-chain acyl-CoA dehydrogenase deficiency: findings from screening approximately 1.1 million newborn infants. J Med Screen 2008;15:112-117[Abstract/Free Full Text]
3. Kølvraa S, Gregersen N, Christensen E, Hobolth N. In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence for a defect in general acyl-CoA dehydrogenase. Clin Chim Acta 1982;126:53-67. [CrossRef][ISI][Medline]
4. Coates PM, Hale DE, Stanley CA, Corkey BE, Cortner JA. Genetic deficiency of medium-chain acyl coenzyme A dehydrogenase: studies in cultured skin fibroblasts and peripheral mononuclear leukocytes. Pediatr Res 1985;19:671-676[ISI][Medline] (Pubitemid 15006481)
5. Howat AJ, Bennett MJ, Variend S, Shaw L. Deficiency of medium chain fatty acylcoenzyme A dehydrogenase presenting as the sudden infant death syndrome. BMJ 1984;288:976.[Free Full Text] (Pubitemid 14115356)
6. Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu Rev Physiol 2002;64:477-502. [CrossRef][ISI][Medline] (Pubitemid 34259237)
7. Grosse SD, Khoury MJ , Greene CL, Crider KS, Pollit RJ.The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update. Genet Med 2006;8:205-212[ISI][Medline] (Pubitemid 43756052)
8. Chace DH, Hillman SL, Van Hove JL, Naylor EW. Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clin Chem 1997;43:2106-2113[Abstract/Free Full Text] (Pubitemid 27497809)
9. Watson MS, Mann MY, Lloyd-Puryear MA, Rinaldo P, Howell RR, eds. Newborn screening: towards a uniform screening panel and system. Genet Med 2006;8:1-252.[ISI][Medline]
10. Wilcken B, Haas M, Joy P, Wiley V, Chaplin M, Black C, et al. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet 2007;369:37-42. [CrossRef][ISI][Medline] (Pubitemid 46027226)
11. Bodamer OA, Hoffmann GF, Lindner M. Expanded newborn screening in Europe 2007. J Inherit Metab Dis 2007;30:439-444[CrossRef][ISI][Medline] (Pubitemid 47377039)
12. House of Lords Science and Technology Committee. Genomic medicine. 2008. www.parliament.uk/documents/upload/stGMGovernmentResponse.pdf.
13. Lean MEJ, Mann JI, Hoek JA, Elliot RM, Schofield G. Translational research: from evidence-based medicine to sustainable solutions for public health problems. BMJ 2008;337:a863.[Free Full Text]